X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES NOVARTIS ALKEM LABORATORIES/
NOVARTIS
 
P/E (TTM) x - 341.7 - View Chart
P/BV x 6.2 16.8 36.9% View Chart
Dividend Yield % 0.7 1.7 40.7%  

Financials

 ALKEM LABORATORIES   NOVARTIS
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
NOVARTIS
Mar-16
ALKEM LABORATORIES/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs1,589982 161.8%   
Low Rs1,232556 221.5%   
Sales per share (Unadj.) Rs417.5252.9 165.1%  
Earnings per share (Unadj.) Rs56.362.1 90.6%  
Cash flow per share (Unadj.) Rs64.763.3 102.2%  
Dividends per share (Unadj.) Rs12.7010.00 127.0%  
Dividend yield (eoy) %0.91.3 69.2%  
Book value per share (Unadj.) Rs292.9363.6 80.6%  
Shares outstanding (eoy) m119.5731.96 374.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.0 111.1%   
Avg P/E ratio x25.112.4 202.4%  
P/CF ratio (eoy) x21.812.2 179.4%  
Price / Book Value ratio x4.82.1 227.6%  
Dividend payout %22.616.1 140.2%   
Avg Mkt Cap Rs m168,65324,580 686.1%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m9,1711,801 509.2%   
Avg. sales/employee Rs ThNM10,748.9-  
Avg. wages/employee Rs ThNM2,395.2-  
Avg. net profit/employee Rs ThNM2,641.1-  
INCOME DATA
Net Sales Rs m49,9158,083 617.5%  
Other income Rs m1,645829 198.3%   
Total revenues Rs m51,5618,913 578.5%   
Gross profit Rs m8,482234 3,621.8%  
Depreciation Rs m1,00637 2,740.6%   
Interest Rs m6712 37,255.6%   
Profit before tax Rs m8,4511,025 824.4%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m1,606752 213.6%   
Profit after tax Rs m6,7311,986 338.9%  
Gross profit margin %17.02.9 586.5%  
Effective tax rate %19.073.4 25.9%   
Net profit margin %13.524.6 54.9%  
BALANCE SHEET DATA
Current assets Rs m27,06212,678 213.5%   
Current liabilities Rs m15,3242,433 629.8%   
Net working cap to sales %23.5126.7 18.6%  
Current ratio x1.85.2 33.9%  
Inventory Days Days6733 203.4%  
Debtors Days Days4122 183.6%  
Net fixed assets Rs m12,61069 18,221.8%   
Share capital Rs m239160 149.6%   
"Free" reserves Rs m34,49011,460 301.0%   
Net worth Rs m35,02711,621 301.4%   
Long term debt Rs m1,2120-   
Total assets Rs m54,38714,400 377.7%  
Interest coverage x13.6570.5 2.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 163.5%   
Return on assets %13.613.8 98.6%  
Return on equity %19.217.1 112.4%  
Return on capital %24.923.6 105.4%  
Exports to sales %12.90.7 1,738.0%   
Imports to sales %3.118.6 16.6%   
Exports (fob) Rs m6,46160 10,732.7%   
Imports (cif) Rs m1,5401,503 102.5%   
Fx inflow Rs m6,563186 3,523.0%   
Fx outflow Rs m3,0121,821 165.4%   
Net fx Rs m3,552-1,635 -217.3%   
CASH FLOW
From Operations Rs m7,2592,531 286.8%  
From Investments Rs m1,864-8,270 -22.5%  
From Financial Activity Rs m-9,273-386 2,404.1%  
Net Cashflow Rs m-150-6,125 2.4%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 33.1 2.0 1,655.0%  
FIIs % 0.0 1.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 21.5 -  
Shareholders   68,381 41,647 164.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ASTRAZENECA PHARMA  PANACEA BIOTECH  CADILA HEALTHCARE  GSK PHARMA  PLETHICO PHARMA  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 21, 2017 02:41 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - TTK HEALTHCARE COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS